PAA 2.50% 20.5¢ pharmaust limited

Ann: Preliminary MPL antiviral leukaemia preclinical WEHI results, page-9

  1. 1,857 Posts.
    lightbulb Created with Sketch. 2260
    Well,

    This is a convincing opening to orphan drug status & Govt funding as this is prevalent in the indigenous community without any viable treatment.

    It also is supporting the broad spectrum anti-virus as per the govt initiative for covid and beyond.
    2 separate mechanisms of action working to provide the solution.

    This is seriously good.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.